None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: A) Adult men and women aged 18 years or older B) Patients or guardians complain of memory loss C) Through neuropsychological tests, cognitive ability, including memory, is reduced compared to age and education level. D) Maintain overall cognitive function E) No hindrance to daily life F) It should not be dementia according to the judgment of the clinician G) Subjects or their legal representatives voluntarily decide to participate in the study and give written consent after listening to a detailed explanation of this study and fully understanding it
Exclusion criteria
Exclusion criteria: a) any advanced, severe, progressive or unstable disease that could put the patient at risk; B) Any medical or other neurological disease that can explain cognitive decline (e.g., abnormal thyroid function test, vitamin B12 or folic acid deficiency, post-traumatic disease, Huntington's disease, multiple sclerosis, cerebral palsy, encephalitis, meningitis, etc. - diseases affecting the central nervous system) c) any other DSM-V Axis I diagnosis, including primary neurodegenerative dementia other than depression, schizophrenia, or bipolar disorder D) Those who currently have uncontrolled convulsive disease E) A person who has a history of loss of consciousness for more than 1 hour or a brain injury accident that resulted in hospitalization within 3 years F) Hearing or vision impairment that may interfere with the performance of the requirements of the clinical trial G) Those who are judged not to be suitable for research according to the judgment of the researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ADAS-Cog 13 total points | — |
Secondary
| Measure | Time frame |
|---|---|
| ADAS-Cog 13 score by domain, ADCS-ADL-MCI score , K-MMSE 2, CDR, GDeS | — |
Countries
Korea, Republic of
Contacts
Hallym University Medical Center- Chuncheon